<DOC>
	<DOCNO>NCT01359605</DOCNO>
	<brief_summary>The purpose study characterize metabolism excretion ( ADME ) single oral dose [ 14C ] varespladib methyl .</brief_summary>
	<brief_title>Study Assess Metabolism Elimination 14C-Labeled Varespladib Methyl Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Varespladib methyl</mesh_term>
	<criteria>Provision sign , write date informed consent prior study specific procedure Healthy male , 19 55 year age Have body mass index ( BMI ) 18 35 kg/m2 inclusive History presence clinically significant disease disorder opinion investigator Any clinically relevant abnormal finding physical examination , clinical chemistry , haematology , urinalysis , vital sign baseline opinion investigator</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>December 2011</verification_date>
	<keyword>ADME</keyword>
	<keyword>Healthy volunteer</keyword>
</DOC>